FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileResMed Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RMD
ResMed Inc. Stock AnalysisComprehensive stock analysis for ResMed Inc. (RMD) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRMD
RMD
ResMed Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RMD
  1. Home
  2. Stocks
  3. ResMed Inc.

ResMed Inc.

🇺🇸RMD•NYSE

ResMed Inc.

🇺🇸RMD•NYSE
Market cap
$33.50B
Sentiment

Your view on RMD

Mkt Cap
$33.50B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About ResMed Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Michael J. Farrell BE, MBA, SM
Headquarters
9001 Spectrum Center Boulevard, San Diego, CA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Michael J. Farrell BE, MBA, SM
Headquarters
9001 Spectrum Center Boulevard, San Diego, CA, US
Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service.

It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.

The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal.

It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies.

The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for ResMed Inc. from FRC's valuation model, read against the market price. RMD last traded at $238.19, 21.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for ResMed Inc.. Starting points for ResMed Inc.: P/E 21.7, EPS $11.14, beta 0.76 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for ResMed Inc.. ResMed Inc. paid $2.52 per share over the last year — a 1.1% yield at the current $238.19 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for ResMed Inc.. Trailing twelve-month EPS for ResMed Inc. stands at $11.14. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$251.42

average of 12 firms, last 12 months

 

$251.42

Low $213.00

Median $258.50

High $300.00

 

Analyst Ratings

Hold11 firms, last 12 months
  • Strong Buy0
  • Buy3
  • Hold8
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimate$2.99$3.05$12.14$13.25
Low estimate$2.95$2.99$12.09$13.05
High estimate$3.09$3.18$12.23$13.78
No. of analysts991514
Year-ago EPS$2.81$2.86$10.43—
Growth+6.5%+6.7%+16.4%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimate$1.46B$1.46B$5.83B$6.19B
Low estimate$1.45B$1.44B$5.82B$6.09B
High estimate$1.48B$1.47B$5.86B$6.25B
No. of analysts10102221
Year-ago revenue$1.42B$1.43B$5.65B—
Growth+2.3%+1.7%+3.1%—
Recent analyst actions15 rating and price-target changes, latest Nov 2, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for ResMed Inc.. ResMed Inc. has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold RMD20 companies · 8 funds
Compare RMD with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • BSXBoston Scientific CorporationMedical - Devices$63.3B
  • ELMDElectromed, Inc.Medical - Devices$189M
  • FSPKFFisher & Paykel Healthcare Corporation LimitedMedical - Instruments & Supplies$14.2B
  • GEHCGE HealthCare Technologies Inc.Medical - Devices$37.5B
  • GNGBYGetinge AB (publ)Medical - Devices$6.1B
  • INSPInspire Medical Systems, Inc.Medical - Devices$1.7B
  • ISRGIntuitive Surgical, Inc.Medical - Instruments & Supplies$151.7B
  • MDTMedtronic plcMedical - Devices$131.6B

More Medical - Instruments & Supplies companies

  • SDMHFSartorius Stedim Biotech S.A.OTC$21.2B
  • SHWGFShandong Weigao Group Medical Polymer Company LimitedOTC$3.3B
  • ADDLFAddLife AB (publ)OTC$4.9B
  • AHC.AXAustco Healthcare LimitedASX
  • AHICFAsahi Intecc Co., Ltd.OTC$5.6B
  • ANGOAngioDynamics, Inc.NASDAQ$495M
  • ANN.AXAnsell LimitedASX
  • ANSLFAnsell LimitedOTC$3.3B
  • ANSLYAnsell LimitedOTC$3.3B
  • ATRAptarGroup, Inc.NYSE$9.1B
  • ATRCAtriCure, Inc.NASDAQ$2.8B
  • AVTRAvantor, Inc.NYSE$10.4B

ETFs holding ResMed Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.05%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.05%
  • VOVanguard Mid-Cap ETF$103.4B in assets0.32%
  • IVViShares Core SP 500 ETF$852.9B in assets0.05%
  • IHIiShares US Medical Devices ETF$4.0B in assets4.34%
  • SEIQSEI Enhanced U.S. Large Cap Quality Factor ETF$782M in assets2.32%
  • FTGSFirst Trust Growth Strength ETF$1.2B in assets2.06%
  • XOVRERShares Private-Public Crossover ETF$1.4B in assets1.96%

Largest holders first, then the funds most concentrated in RMD.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold ResMed Inc., and how their positions are changing. At a $33.50B market value, institutional positions materially move ResMed Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by ResMed Inc. executives and directors. Shares of ResMed Inc. have traded between $199.92 and $293.81 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming ResMed Inc.. ResMed Inc. is a $33.50B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming ResMed Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for ResMed Inc.. Coverage tracks ResMed Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of ResMed Inc.

RMD Analysis
Good
Past1
Growth5
Health4
Profit4
Value1

News

Latest Market News